Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omega-3 Fatty Acids in Bariatric Gastric Bypass Surgery (OLIVIER)
NCT02206256Phase 4Completed
- Sponsor
- Noordwest Ziekenhuisgroep
- Start
- Nov 2014
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of omega-3 fatty acid in class III obesity, sponsored by Noordwest Ziekenhuisgroep. Started Nov 2014; status: completed.
02
Drugs
omega-3 fatty acid
03
Conditions
class III obesity
Beyond the preview
Go deeper on NCT02206256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02206256.